The Uttarakhand High Court on Tuesday issued notice to the Central Government on a PIL filed against Patanjali Ayurved for making claims about medicine "Coronil" vis-à-vis treatment of the deadly Covid-19 disease, in the absence of requisite permission from the Government.
The matter was listed before the bench of Chief Justice Ramesh Ranganathan and Justice Ramesh Chandra Khulbe, which asked the Assistant Solicitor General of India, representing the Union of India, to remain present during hearing on July 1.
The petition has been filed by a practicing Advocate of the High Court, Mani Kumar stating that the company owners mislead the public when in fact they did not have requisite approval from the Union Ministry of Ayush or the Indian Council of Medical Research (ICMR).
How Patanjali's Unilateral Declaration Of Discovering COVID-19 Cure Violates Law?
The Petitioner has also roped in NIMS University, Rajasthan as a Respondent-party, which purportedly conducted clinical trials on Covid-19 patients for the company, without informing either the Central or the State Government.
On June 23, Patanjali Ayurved had launched 'Coronil and Swasari', claiming that the medicines showed "100% favourable results" for curing Corona virus during clinical trials.
Later in the day, the Ministry of AYUSH clarified that that facts of the claim and details of the stated scientific study are not known to it. The government further asked the Company to stop making such claims and to submit the alleged medicines for government verification.
A complaint against the company owners, Yoga Guru Baba Ramdev (Founder) and Acharya Balkrishna (MD, CEO), has also been filed before a court in Muzaffarpur, Bihar.